Department of Advanced Biomedical Sciences, University Federico II, Via S. Pansini, 5, 80131, Naples, Italy.
Department of Public Health, University Federico II, Naples, Italy.
High Blood Press Cardiovasc Prev. 2024 Jul;31(4):405-410. doi: 10.1007/s40292-024-00655-z. Epub 2024 Jun 15.
No data are available on the diagnostic algorithms recommended by guidelines for the assessment of diastolic dysfunction (DD) in patients with arterial hypertension.
To fill this gap, we evaluated diastolic function in hypertensive patients with and without LVH matched with healthy subjects by applying 2016 American Society of Echocardiography-European Association of Cardiovascular Imaging Guidelines for the evaluation of LV diastolic function.
717 healthy and hypertensives with normal LV ejection fraction and with and without LV hypertrophy (LVH), matched 1:1:1 from two prospective registries, represented the study population.
By applying algorithm A, indeterminate pattern was found in 0.4% of healthy, in 6.3% of hypertensives without LVH, and in 21% with LVH (overall p < 0.05 vs. healthy). DD was absent in healthy, however present in 2 and 8% of hypertensives without and with LVH (p = 0.06 and p = 0.001 vs. healthy, respectively). By applying algorithm B, no cases of indeterminate pattern were found. DD was observed in 2.9% of healthy, 7 and 10.5% of hypertensives without and with LVH (p < 0.05 vs. healthy).
The use of algorithm A should be limited only to truly normal subjects, whereas algorithm B should be applied to all patients with hypertension, even without comorbidities and irrespective of LVH.
目前尚无指南推荐的评估动脉高血压患者舒张功能障碍(DD)的诊断算法的数据。
为了填补这一空白,我们通过应用 2016 年美国超声心动图学会-欧洲心血管影像协会评估左心室舒张功能的指南,评估了伴有和不伴有左心室肥厚(LVH)的高血压患者的舒张功能。
717 名健康人和高血压患者,左心室射血分数正常,伴有和不伴有 LVH,从两个前瞻性登记处匹配 1:1:1,构成了研究人群。
应用算法 A,健康者中不确定模式的发生率为 0.4%,无 LVH 的高血压者中为 6.3%,有 LVH 的高血压者中为 21%(总体 p<0.05 与健康者相比)。DD 在健康者中不存在,但在无 LVH 和有 LVH 的高血压者中分别存在 2%和 8%(p=0.06 和 p=0.001 与健康者相比)。应用算法 B,未发现不确定模式的病例。DD 在健康者中发生率为 2.9%,无 LVH 和有 LVH 的高血压者中分别为 7%和 10.5%(与健康者相比,p<0.05)。
算法 A 应仅用于真正的正常人群,而算法 B 应应用于所有高血压患者,即使没有合并症且不论 LVH 情况如何。